Charles J. Arntzen, PhD
Regents’ Professor and Florence Ely Nelson Presidential Chair
The Biodesign Institute
Arizona State University
Dr. Arntzen was appointed to an endowed chair at Arizona State University in 2000. Previously, he had served as President and CEO of Boyce Thompson Institute — a not-for-profit corporation affiliated with Cornell University; as Director of Research at the Dupont Company; as Director of the MSU-DOE Plant Research Laboratory at Michigan State University; and as Deputy Chancellor for Agriculture and Dean, College of Agriculture and Life Sciences and Director of the Texas Agricultural Experiment Station in the Texas A&M University System. He was elected to the U.S. National Academy of Sciences in 1983. He is a fellow of The American Association for the Advancement of Science, received the Award for Superior Service from the U.S. Department of Agriculture, served as chairman of the National Biotechnology Policy Board of the National Institutes of Health, and served for eight years on the Editorial Board of SCIENCE. In 2001-09 he was a member of President George W. Bush’s Council of Advisors on Science & Technology, and from 2004-09 on the National Nanotechnology Oversight Board. Dr. Arntzen’s private sector service includes membership on Board of Directors of several companies, including DeKalb Genetics (prior to sale to Monsanto). He currently serves on the Board of Directors of Advanced BioNutrition, Inc. and is on the Advisory Board of the Burrill and Company’s Agbio Capital Funds and The Nutraceuticals Fund.
For the last 20 years, Dr. Arntzen has lead a team to explore the use of green plants as a manufacturing system for pharmaceutically active proteins. Their current efforts are focused upon a mucosal vaccine to prevent norovirus infections, and the development of a filovirus post-exposure protection system (active and passive immunization).